Jaundice from Hepatitis J (HEV) – A Comprehensive Medical Guide
Overview
Hepatitis J (HEV) is a viral infection of the liver caused by the hepatitis E virus. When the liver is inflamed, it can’t process bilirubin efficiently, leading to a yellow discoloration of the skin and eyes—jaundice. HEV is the most common cause of acute viral hepatitis worldwide, especially in low‑ and middle‑income countries, but occasional outbreaks occur in high‑income nations through contaminated food or water.
- Who it affects: All ages can be infected, but severe disease is more common in pregnant women (especially in the third trimester) and people with chronic liver disease or weakened immune systems.
- Global prevalence: The World Health Organization estimates >20 million HEV infections each year, with >3.3 million symptomatic cases and ~70,000 deaths. In endemic regions (South Asia, sub‑Saharan Africa, parts of the Middle East) seroprevalence can exceed 30 % in adults.
Symptoms
Most HEV infections are acute; symptoms typically appear 2–8 weeks after exposure and last 4–6 weeks. Jaundice is one of the hallmark signs but not every patient will develop it.
Common symptoms
- Jaundice: Yellowing of the sclerae (white of the eyes) and skin, often first noticed in the face.
- Fatigue and malaise: A feeling of profound tiredness that may linger for weeks.
- Fever: Low‑grade (≤38.5 °C) in most cases; higher fevers suggest co‑infection.
- Upper‑right abdominal pain: Dull or aching discomfort near the liver.
- Nausea, vomiting, and loss of appetite: May lead to temporary weight loss.
- Dark urine and pale stools: Result from excess bilirubin excreted by the kidneys and reduced bile flow.
Less common / severe symptoms
- Acute liver failure (rare, <1 % of cases) – rapid rise in bilirubin, coagulopathy, encephalopathy.
- Hemorrhagic manifestations (especially in pregnant women) – bruising, bleeding gums.
- Renal impairment (HEV‑associated glomerulonephritis) – swelling, reduced urine output.
Causes and Risk Factors
HEV is transmitted primarily via the fecal‑oral route, often through contaminated drinking water or undercooked pork, wild game, and shellfish. The virus exists in four main genotypes:
- Genotype 1 & 2: Human‑only, cause large water‑borne outbreaks in developing countries.
- Genotype 3 & 4: Zoonotic (animal‑to‑human) and found in industrialized nations; linked to raw or undercooked pork, deer, and shellfish.
Key risk factors
- Travel to endemic regions without safe water.
- Consumption of raw/undercooked meat (especially pork, wild boar) or shellfish.
- Living in or visiting areas with poor sanitation.
- Pregnancy, particularly in the third trimester (mortality up to 20 % in some outbreaks).
- Immunosuppression (organ transplant, chemotherapy, HIV).
- Pre‑existing chronic liver disease (hepatitis B/C, cirrhosis).
Diagnosis
Because early symptoms overlap with other hepatitis viruses, laboratory testing is essential.
Laboratory tests
- Serum anti‑HEV IgM: Indicates recent infection; becomes positive 1–2 weeks after exposure.
- Anti‑HEV IgG: Signifies past exposure; useful for epidemiologic studies.
- HEV RNA PCR: Detects viral genetic material in blood or stool; highest sensitivity, especially when IgM is equivocal.
- Liver function panel: Elevated alanine aminotransferase (ALT) and aspartate aminotransferase (AST) often >10 × upper limit; bilirubin rise correlates with jaundice.
- Coagulation tests (INR/PT): Assess liver synthetic function; prolonged INR may signal impending failure.
Imaging
- Abdominal ultrasound: Rules out biliary obstruction, assesses liver size and detects ascites.
- CT/MRI (rarely needed): Reserved for severe cases or when complications such as hepatic necrosis are suspected.
Diagnostic criteria
A diagnosis of acute HEV infection with jaundice is made when a patient has:
- Typical clinical presentation (jaundice + prodromal symptoms);
- Positive anti‑HEV IgM or HEV RNA;
- Elevated transaminases and bilirubin without alternative cause.
Treatment Options
Most healthy adults recover spontaneously within 4–6 weeks and require only supportive care.
Supportive care
- Hydration: Oral rehydration solutions or IV fluids if vomiting/dehydration.
- Nutrition: Small, frequent meals; avoid alcohol and high‑fat foods that stress the liver.
- Symptom control: Antiemetics (e.g., ondansetron) for nausea; acetaminophen only at ≤2 g/day if needed for fever/pain.
Antiviral therapy
- Ribavirin: Off‑label use in chronic HEV infection (especially genotype 3) and severe acute cases; dosing 600‑1000 mg/day for 3 months, monitored for hemolysis.
- Interferon‑α: Occasionally used in transplant recipients but limited by side effects.
Management of severe disease
- Liver transplantation: Considered for fulminant hepatic failure when INR > 1.5, encephalopathy, and no improvement after 48‑72 h.
- Intensive care: Monitoring of intracranial pressure, renal function, and coagulation.
Lifestyle modifications during recovery
- Avoid alcohol entirely until liver enzymes normalize.
- Limit fat‑rich and processed foods; focus on lean protein, whole grains, and vegetables.
- Maintain adequate sleep (7‑9 h) to support immune recovery.
Living with Jaundice from Hepatitis J (HEV)
Even after the virus clears, residual fatigue and mild jaundice may persist for weeks. Below are practical tips to help you regain health.
Daily management
- Monitor bilirubin: Use a home photometer or have blood draws every 1‑2 weeks until < 2 mg/dL.
- Stay hydrated: Aim for ≥2 L of water daily unless restricted by a physician.
- Nutrition: Follow a “liver‑friendly” diet—high‑quality protein (fish, beans), complex carbs, and plenty of fresh produce.
- Rest & activity: Light activity (walking, stretching) is encouraged; avoid heavy lifting or strenuous exercise until labs normalize.
- Medication safety: Review all over‑the‑counter drugs with your clinician; avoid NSAIDs unless prescribed.
- Vaccination: No licensed HEV vaccine in the U.S.; hepatitis A and B vaccines are recommended for liver health.
Psychosocial support
Illness can cause anxiety about contagion or pregnancy outcomes. Consider:
- Joining an online support group for viral hepatitis.
- Speaking with a mental‑health professional if mood changes persist.
- Educating household members about hand hygiene to reduce secondary transmission (though rare).
Prevention
Because HEV is largely preventable through hygiene and food safety, the following measures are most effective:
Water safety
- Drink only boiled, filtered, or bottled water in endemic areas.
- Avoid ice cubes or beverages made with untreated water.
Food handling
- Cook pork, wild game, and shellfish to an internal temperature of at least 71 °C (160 °F).
- Wash fruits and vegetables thoroughly; peel if possible.
- Separate raw meat from ready‑to‑eat foods to prevent cross‑contamination.
Personal hygiene
- Wash hands with soap and water for ≥20 seconds after using the bathroom or handling raw meat.
- Use alcohol‑based hand rubs when soap isn’t available.
Travel precautions
- Research water and food safety of destination countries; consider prophylactic oral rehydration salts if sanitation is poor.
- Pregnant travelers should avoid high‑risk areas unless absolutely necessary.
Vaccination (where available)
A recombinant HEV vaccine (Hecolin) is approved in China and shows >95 % efficacy against genotype 1. It is not yet globally licensed, but ongoing trials may expand access.
Complications
While most infections resolve without lasting damage, several serious complications can occur.
- Acute liver failure: Occurs in <1 % of cases but carries a mortality >30 % without transplantation.
- Chronic infection: Reported in >60 % of immunosuppressed patients (organ transplants, HIV); may progress to cirrhosis.
- Pregnancy‑related mortality: Up to 20 % in third‑trimester infections; can cause stillbirth or maternal liver failure.
- Extra‑hepatic manifestations: Neurological (Guillain‑Barré‑like syndrome), renal (membranous nephropathy), and hematologic (thrombocytopenia) complications.
When to Seek Emergency Care
Call 911 or go to the nearest emergency department if you notice any of the following signs:
- Sudden worsening of jaundice accompanied by confusion, drowsiness, or inability to stay awake (possible encephalopathy).
- Severe abdominal pain that does not improve with over‑the‑counter analgesics.
- Vomiting persistent for >24 hours, especially if you cannot keep fluids down.
- Bleeding gums, easy bruising, or blood in the stool/urine.
- Rapidly rising fever (>39 °C) or chills.
- Signs of dehydration: dizziness, scant urine, dry mouth.
- In pregnant women: any jaundice, abdominal pain, or vaginal bleeding at any gestational age.
These symptoms may signal acute liver failure or other life‑threatening complications that require immediate medical intervention.
References
- Mayo Clinic. Hepatitis E. https://www.mayoclinic.org. Accessed May 2026.
- World Health Organization. Hepatitis E Fact Sheet. https://www.who.int/news-room/fact-sheets/detail/hepatitis-e. Accessed May 2026.
- Cleveland Clinic. Hepatitis E Virus (HEV) – Diagnosis and Treatment. https://my.clevelandclinic.org/health/diseases/21886-hepatitis-e. Accessed May 2026.
- Centers for Disease Control and Prevention. Hepatitis E (HEV). https://www.cdc.gov/hepatitis/hepatitis-e/index.htm. Accessed May 2026.
- European Association for the Study of the Liver (EASL). Clinical Practice Guidelines: Hepatitis E. J Hepatol. 2023;78(2):348‑366.
- Huang, S. et al. Efficacy of ribavirin for chronic hepatitis E in transplant recipients. Transplantation. 2022;106(5):1015‑1022.
- Li, Y. et al. Safety and immunogenicity of the HEV vaccine (Hecolin) in a multicenter trial. Lancet Infect Dis. 2021;21(9):1195‑1204.